Research Publications
The latest from Maverex.
Latest Posts
Find our peer-reviewed research publications across oncology, cardiovascular, infectious disease and much more.
Indirect calorimetry is a cost-saving strategy to manage patients in hospital intensive care
Wright A, Shepelev J, Kriz A. PAM5 Indirect calorimetry is a cost-saving strategy to manage patients in hospital intensive care. Value Health 2020;23(Suppl 2):S409
The clinical and cost impact of adherence to chronic obstructive pulmonary disease guideline recommendations in England- a cost consequence model
Vioix H, Wright A, de Silva S, Langham S, Gayle A, Soto J, Cook J, Capstick T, Quint J. PRS18 The clinical and cost impact of adherence to chronic obstructive pulmonary disease guideline recommendations in England- a cost consequence model. Value Health 2020;23(Suppl 2):S719
Disease severity, comorbid conditions, treatment patterns, and flares in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort Analysis
Langham J, Barut V, Samnaliev M, Langham S, Weir S, Wang X, Desta B, Hammond ER. SAT0216 Disease severity, comorbid conditions, treatment patterns, and flares in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort AnalysisIS. Ann Rheum Dis 2020;79(Suppl 1):1050–1
Health care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort study
Samnaliev M, Barut V, Weir S, Langham J, Langham S, Wang X, Desta B, Hammond ER. THU0550 Health care utilization and costs in adults with systemic lupus erythematosus in the United Kingdom: a real-world observational retrospective cohort study. Ann Rheum Dis 2020;79(Suppl 1):515–6
Patient engagement process in rare disease: how does it differ between countries?
Skeldon G, Adkins E, Ayre S, Langham S, Nicholson L. PRO95 Patient engagement process in rare disease: how does it differ between countries? Value Health 2020;23(Suppl 2):S706
A review of exceptional circumstances marketing authorisations granted by the European Medicines Agency
Marjenberg Z, Teague R, Skeldon G. PMU50 A review of exceptional circumstances marketing authorisations granted by the European Medicines Agency. Value Health 2020;23(Suppl 2):S611
Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis
Yazdany J, Pooley N, Langham J, Nicholson L, Langham S, Embleton N, Wang X, Desta B, Barut V, Hammond E. Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis. RMD Open 2020;6(2):e001247
The risk of venous thromboembolic events in adult patients with systemic lupus erythematosus: a systematic review and meta-analysis
Pooley N, Yazdany J, Langham J, Nicholson L, Langham S, Embleton N, Wang X, Desta B, Barut V, Hammond ER. The risk of venous thromboembolic events in adult patients with systemic lupus erythematosus: a systematic review and meta-analysis. Ann Rheum Dis 2019;78(Suppl 2):A804
The increasing use and acceptance of alternative statistical approaches to indirect comparison in the NICE HTA submission process
Pooley N, Marjenberg Z, Embleton N, Langham S. The increasing use and acceptance of alternative statistical approaches to indirect comparison in the National Institute of Health and Care Excellence (NICE) health technology assessment (HTA) submission process. Value Health 2019:22(Suppl 3):S814
